文献速递脑血管病

区域卒中救治干预提高急性缺血性卒中溶栓治疗

Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2018-01-01

该研究回顾性分析2014年4月至2016年6月26家东南德克萨斯区域咨询委员会医院的前瞻性溶栓数据,比较数据揭盲并告知医院首席执行官前后的r-tPA(重组组织型纤溶酶原激活剂)给药率。

要点

  • 干预与r-tPA给药率提高21.1%相关。
  • 门-针时间≤60分钟的r-tPA给药率提高38.5%。

核心结论

  • 透明的区域数据共享与r-tPA给药改善及医疗费用节省相关。

研究设计与样本

  • 回顾性分析2014年4月至2016年6月收集的26家东南德克萨斯区域咨询委员会医院的前瞻性溶栓治疗数据。
  • 对照(盲态)期为2014年第二季度至2015年第二季度,其后于2015年第三季度揭盲。

主要发现

  • 干预与r-tPA给药率提高21.1%相关。
  • 干预与门-针时间≤60分钟的r-tPA给药率提高38.5%相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- The aims of this study were to investigate the effect of an intervention to unblind data on r-tPA (recombinant tissue-type plasminogen activator) administration and sharing data with chief executive officers of participating hospitals, on r-tPA administration rates postintervention and on potential healthcare cost savings implemented at 26 Southeast Texas Regional Advisory Council hospitals. Methods- Retrospective analysis of prospective data on thrombolytic therapy from 26 Southeast Texas Regional Advisory Council hospitals, collected between April 2014 and June 2016. The control (blinded) period (Q2-2014 to Q2-2015) was followed by unblinding (Q3-2015). Results- Intervention was associated with 21.1% increase in r-tPA administration rates, with 38.5% increase in r-tPA administration with door-to-needle time ≤60 minutes. An absolute increase in r-tPA administration of 2.1% was seen with an average lifetime cost savings of $3.6 million. Conclusions- Transparent regional data sharing was associated with improved r-tPA administration and healthcare cost savings.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Damani RH, Anand S, Asgarisabet P, et al. Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke. Stroke. 2018. PMID: 29991653. doi:10.1161/STROKEAHA.118.021109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。